← Evidence map

ReviewFrontiers in immunology

Can Resveratrol-Inhaled Formulations Be Considered Potential Adjunct Treatments for COVID-19?

Giovanni A Rossi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

33 papers cite it

2021
2022
2023
2024
2025
2026
trialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 34093569